There is no commercial support for this activity.

About These Speakers

Jordan Cattie, PhD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Emory School of Medicine. She serves as Associate Director of Adult Outpatient Psychiatry at Emory Clinic, and Director of the Emory OCD & Anxiety Intensive Program. Dr. Cattie's work aims to increase access to effective mental healthcare through the provision of clinical care, training and dissemination of evidence-based practices, and advocacy. She provides didactic trainings and clinical supervision in Acceptance and Commitment Therapy (ACT), which aims to promote psychological and behavioral flexibility in pursuit of valued living. Clinically, she is interested in integrating third-wave behavioral therapies with other empirically informed interventions to provide comprehensive care for patients and families.

Dr. Katie Cullum is a Licensed Clinical Psychologist and Assistant Professor at Emory University Department of Psychiatry and Behavioral Sciences. Dr. Cullum's clinical work and research focuses on the treatment OCD and related disorders using Exposure with Response Prevention (ERP) and Acceptance and Commitment Therapy (ACT). She provides supervision and training in the ACT model and seeks to increase access to evidence-based care through her involvement in education and outreach. Dr. Cullum is a founding member of Emory University School of Medicine’s Caring Communities for COVID-19 and a board member of OCD Georgia.  

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Katherine A. Cullum, PhD, reports that she has no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. She will discuss off-label use of pharmaceuticals in this presentation. All conflicts have been mitigated through review. 

Jordan Elizabeth Cattie, PhD, reports that she has no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. She will discuss off-label use of pharmaceuticals in this presentation. All conflicts have been mitigated through review. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Elizabeth Ryznar, MD, MSc, Louis J. Marino, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, April Sobiech, LCSW-C, Latia Suite, LCSW-C, Rachel Smolowitz, PhD, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, Lisa E. Seldon, DNP, MSA, RN, NEA-BC, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.